2022 Global Drug Bioavailability Enhancement Summit

August 23-24, 2022, Philadelphia Marriott Downtown, Philadelphia, PA 

REGISTER NOW      ATTENDEES LIST

2022 Global Drug Bioavailability Enhancement Summit

August 23-24, 2022, Philadelphia Marriott Downtown, Philadelphia, PA

REGISTER NOW      ATTENDEES LIST

2022 Global Drug Bioavailability Enhancement Summit

August 23-24, 2022, Philadelphia Marriott Downtown, Philadelphia, PA

REGISTER NOW      ATTENDEES LIST

2022 Global Drug Bioavailability Enhancement Summit

May 23-24, 2022, Philadelphia, PA | In-Person & Virtual Summit

2022 Global Drug Bioavailability Enhancement Summit

May 23-24, 2022, Philadelphia, PA | In-Person & Virtual Summit

2022 Global Drug Bioavailability Enhancement Summit

May 23-24, 2022, Philadelphia, PA | In-Person & Virtual Summit

Register to attend for only $349 (virtually) or $1295 (in person - saving 35%). Offer expires in:

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

Are you tasked with improving drug performance, bioavailability and patient adherence? Would you like to uncover new strategies to reduce dosage, cost and decrease time-to-market on products?

Check out the 2022 Global Drug Bioavailability Enhancement Summit program agenda and walk away with over 2 years of novel drug formulation and bioavailability enhancement approaches strategies. Learn directly from 30+ senior drug bioavailability pioneers and network with 120+ of senior drug development innovators this coming August in Philadelphia, PA.

2022’s 2-Day program showcases industry’s latest formulation and delivery technologies for enhancing solubility and maximizing bioavailability. 2022’s Summit will share cutting edge research on the development, characterization and manufacture of formulations that span multiple modalities.

Interested to showcase or present your platform technology to 100’s of senior pharma drug product development attendees?

  • Precision medicine & healthcare delivery
  • Rationale formulation design for poorly soluble compounds
  • In-vivo – in-vitro correlation
  • Solution behavior of amorphous solid dispersions
  • Nanosuspension for improving the bioavailability
  • Early formulation screening in drug discovery
  • 3D printing for biopharmaceuticals
  • Enhancing patient adherence via drug delivery
  • Innovative strategies around drug / device combinations

Want to attend but need help to convince your boss?

Let us help by generating you a custom message for you to send to your boss. Email it, talk them through it in person, tweet it to them 280 characters at a time: up to you.

2021’s Speakers Included:

Manish Gupta, PhD

Manish Gupta, PhD

Senior Director, Pharmaceutical Development - Sterile

GlaxoSmithKline

Dedong Wu, PhD

Dedong Wu, PhD

Senior Scientist, Solid State

AstraZeneca

Arijit Chakravarty, PhD

Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

Rick Panicucci, PhD

Rick Panicucci, PhD

Senior Vice President, CMC

QED Therapeutics

Saji Vijayan, PhD

Saji Vijayan, PhD

Vice President- R&D Strategy

Endo Pharmaceuticals

Sune Anderson, PhD

Sune Anderson, PhD

Principal Scientist, Spray Drying

Johnson & Johnson

Susan Rosenbaum

Susan Rosenbaum

Founder, Chairman & Chief Executive Officer

Lauren Sciences

Stephen Tindal, PhD

Stephen Tindal, PhD

Director, Science & Technology

Catalent Pharma Solutions

Melanie Marota, PhD

Melanie Marota, PhD

Associate Principal Scientist, Pharmaceutical Sciences

Merck & Co.

Eric	Munson, PhD

Eric Munson, PhD

Patrick DeLuca Endowed Professor in Pharmaceutical Technology, Department of Pharmaceutical Sciences

Purdue University

Di Wu, PhD

Di Wu, PhD

Senior Scientist, Formulation Development

Merck & Co.

Stephen Stern, PhD

Stephen Stern, PhD

Director of Research and Development, Head of the Pharmacology and Toxicology Section

Nanotechnology Characterization Laboratory

Dabing Chen, PhD

Dabing Chen, PhD

Senior Principal Scientist

Boehringer Ingelheim

Xin Liu, PhD

Xin Liu, PhD

Associate Director of Pharmaceutical Product Development

Triasek

Christoph Nüboldt

Christoph Nüboldt

Senior Researcher

INVITE GmbH

Sudhakar Garad, PhD

Sudhakar Garad, PhD

Global Head of Chemical and Pharmaceutical Profiling

Novartis

30+

Industry-led Speakers

100's

of Senior Participants

12+

Networking Hours

16

Tech Exhibitors

Previous Sponsors & Exhibitors

Gattefosse
Gattefosse
Gattefosse
Gattefosse
Gattefosse
Fluid Air
Absorption Systems
Gattefosse
Gattefosse

Download The Bioavailability Previous Attendee List

Partnering with the 2022 Summit will also help you:

  • Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
  • Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
  • Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
  • Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions

Attendee Pricing

Super Early-Bird

Register before June 3, 2022

Virtual Summit

$349

In-Person Summit

$1395

In-Person Summit + 1 Workshop

$1595

In-Person Summit + 2 Workshops

$1695

Early Bird

Register before Aug 19, 2022

Virtual Summit

$449

In-Person Summit

$1795

In-Person Summit + 1 Workshop

$1995

In-Person Summit + 2 Workshops

$2095

Standard Pricing

Register Aug 20, 2022 Onwards

Virtual Summit

$449

In-Person Summit

$1995

In-Person Summit + 1 Workshop

$2195

In-Person Summit + 2 Workshops

$2295

Featured Posts

Prodrug Approach for Improving Bioavailability

Prodrug Approach for Improving Bioavailability

A prodrug is a medication or compound that metabolizes into a pharmacologically active drug after administration, offering opportunities to optimize the pharmaceutical property to improve bioavailability. Approximately 10% of all marketed drugs worldwide can be...

read more
Register

Ready To Join Us?

Pin It on Pinterest

Share This